AnalystsSerge BelangerSerge Belanger's Stock Forecasts
AnalystsSerge Belanger
Analyst Ranking
Top 2%
#86 out of 4981 analysts
Average Return
+12.99%
Win Rate
54%197 out of 366
Risk vs Reward
Poor
Good
Serge Belanger's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arcutis Biotherapeutics IncARQT | +297.44% | $2.34 | $9.30 | 2023-11-06 - 2024-11-05 | Buy |
Arcutis Biotherapeutics IncARQT | +297.44% | $2.34 | $9.30 | 2023-11-06 - 2024-11-05 | Buy |
Cormedix IncCRMD | +230.33% | $3.33 | $11.00 | 2023-11-15 - 2024-11-14 | Buy |
Cormedix IncCRMD | +209.65% | $3.42 | $10.59 | 2024-03-12 - 2025-03-11 | Buy |
Trevi Therapeutics IncTRVI | +189.23% | $2.60 | $7.52 | 2024-12-04 - 2025-08-15 | Buy |
Serge Belanger Analyst Color
Get additional color on Serge Belanger's coverage of popular stocks
Serge Belanger's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Amphastar Pharmaceuticals IncAMPH | 1 | Buy | $36.00 | +20.68% | Upgrades | 5 days ago |
Liquidia CorpLQDA | 32 | Buy | $36.00 | +38.73% | Maintains | 5 days ago |
Heron Therapeutics IncHRTX | 21 | Buy | $3.00 | +125.56% | Maintains | 9 days ago |
Trevi Therapeutics IncTRVI | 20 | Buy | $22.00 | +192.55% | Maintains | 9 days ago |
Arcutis Biotherapeutics IncARQT | 22 | Buy | $22.00 | +30.25% | Maintains | 10 days ago |
Viridian Therapeutics IncVRDN | 18 | Buy | $34.00 | +83.39% | Maintains | 11 days ago |
Evolus IncEOLS | 16 | Hold | $22.00 | +226.89% | Downgrades | 11 days ago |
Ocular Therapeutix IncOCUL | 4 | Buy | $15.00 | +18.86% | Maintains | 12 days ago |
Biocryst Pharmaceuticals IncBCRX | 16 | Buy | $17.00 | +103.11% | Maintains | 13 days ago |
Clearside Biomedical IncCLSD | 16 | Hold | $3.00 | +609.22% | Downgrades | a month ago |
Cormedix IncCRMD | 18 | Buy | $20.00 | +54.68% | Maintains | 2 months ago |
Newamsterdam Pharma Co NvNAMS | 9 | Buy | $40.00 | +59.55% | Reiterates | 2 months ago |
Cytokinetics IncCYTK | 23 | Buy | $72.00 | +86.19% | Reiterates | 3 months ago |
Moonlake ImmunotherapeuticsMLTX | 12 | Buy | $66.00 | +21.35% | Reiterates | 3 months ago |
Xenon Pharmaceuticals IncXENE | 12 | Buy | $55.00 | +43.87% | Maintains | 3 months ago |
Pacira Biosciences IncPCRX | 27 | Buy | $30.00 | +21.07% | Maintains | 3 months ago |
Esperion Therapeutics IncESPR | 20 | Buy | $4.00 | +95.12% | Maintains | 3 months ago |
Collegium Pharmaceutical IncCOLL | 21 | Buy | $46.00 | +21.89% | Reiterates | 4 months ago |
Kalvista Pharmaceuticals IncKALV | 18 | Buy | $28.00 | +117.39% | Reiterates | 4 months ago |
Verrica Pharmaceuticals IncVRCA | 14 | Hold | $120.00 | +1,913.42% | Downgrades | 10 months ago |
Revance Therapeutics IncRVNC | 16 | Buy | $12.00 | N/A | Reiterates | a year ago |
Dice Therapeutics IncDICE | 1 | Buy | $56.00 | N/A | Reiterates | 2 years ago |
Tricida IncTCDAQ | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Phasebio Pharmaceuticals IncPHASQ | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Aerie Pharmaceuticals IncAERI | 5 | Hold | N/A | N/A | Downgrades | 3 years ago |
Clarus Therapeutics Holdings IncCRXTQ | 4 | Hold | N/A | N/A | Downgrades | 3 years ago |
Akebia Therapeutics IncAKBA | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Zogenix IncZGNX | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Flexion Therapeutics IncFLXN1 | 1 | Buy | $18.00 | N/A | Maintains | 4 years ago |
Calcimedica IncCALC | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Gw Pharmaceuticals PLCGWPH | 3 | Hold | N/A | N/A | Downgrades | 5 years ago |
Zynerba Pharmaceuticals IncZYNE | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.